Jaewon Hyung
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Prognostic impact of blood Epstein-Barr virus-DNA in patients with peripheral T-cell lymphoma, not otherwise specified.
Journal: British journal of haematology
Published: March 18, 2026
Transcriptomic profiling of an in vivo diffuse large B-cell lymphoma model reveals molecular programs underlying CNS dissemination.
Journal: Annals of hematology
Published: January 29, 2026
Artificial intelligence-based prediction of claudin 18.2 expression and immune phenotype from routine histology to guide treatment decisions in patients with gastric cancer.
Journal: ESMO open
Published: January 25, 2026
Neoadjuvant Chemotherapy for Gastric Cancer: Evolving Approaches and Supporting Evidence.
Journal: Journal of gastric cancer
Published: September 20, 2025
Genomic Correlations for Clinical Outcomes in HER2-positive Advanced Gastric Cancer Treated Using Trastuzumab-based Therapy.
Journal: Anticancer research
Published: August 14, 2025
Risk factors and clinical outcomes associated with leptomeningeal carcinomatosis in gastric cancer.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: August 07, 2025
Association between the presence of malignant ascites and survival outcomes in gastric cancer patients treated with nivolumab plus chemotherapy.
Journal: International journal of cancer
Published: July 29, 2025
Prognostic significance of pretransplant 18F-FDG PET/CT metrics in relapsed/refractory diffuse large B-cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation.
Journal: British journal of haematology
Published: June 17, 2025
Association between FGFR2b Positivity and Survival Outcomes of Patients with Gastric Cancer Treated with First-Line Nivolumab Plus Chemotherapy.
Journal: Cancer research and treatment
Published: June 06, 2025
Clinical Benefit of Adjuvant Capecitabine According To Residual Cancer Burden in Patients With Triple-Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy.
Journal: Clinical breast cancer
Published: May 22, 2025
Cytomegalovirus Infection After Chimeric Antigen Receptor T-Cell Therapy or Bispecific Antibody Treatment for Hematologic Malignancies.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: April 10, 2025
Last Updated: 09/26/2026